Exelixis Inc Share Price
Exelixis Inc (EXEL) had Share Price of $5.40 per share as of 2015-07-31, per its 10-K filed 2018-02-26.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:SharePrice · last filed 2018-02-26
- 2015-07-31: Share Price $5.40.
- 2015-07-29: Share Price $5.40.
- 2014-01-31: Share Price $8.00.
- 2012-08-31: Share Price $4.25.
| Period end | Share Price |
|---|---|
| 2015-07-31 | $5.40 10-K · filed 2018-02-26 |
| 2015-07-29 | $5.40 10-Q · filed 2015-11-10 |
| 2014-01-31 | $8.00 10-K · filed 2017-02-27 |
| 2012-08-31 | $4.25 10-K · filed 2015-03-02 |
| 2012-08-14 | $4.25 10-K · filed 2014-02-20 |
| 2012-02-29 | $5.17 10-K · filed 2015-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |